학술논문

Gut microbiome signatures correlate with overall survival among patients receiving eribulin with or without pembrolizumab for hormone receptor-positive metastatic breast cancer
Document Type
Journal
Source
CANCER RESEARCH; MAR 1 2023, 83 5, 2p. Supplement: S
Subject
Language
English
ISSN
15387445